OTC · Healthcare
Sonendo, Inc. (SONX)
As-reported financials and recent SEC filings for Sonendo, Inc., latest fiscal period FY2024. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$31.7M
Net income
$-28.0M
Net margin
-88.4%
Diluted EPS
$-59.03
ROE
-540.0%
P/E (TTM)
—
Market cap
—
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $31.7M | $34.6M | $41.7M | $33.2M | $23.4M |
| Gross profit | $11.8M | $4.7M | $10.5M | $8.3M | $3.9M |
| Operating income | $-29.4M | $-59.3M | $-58.2M | $-44.4M | $-42.8M |
| Net income | $-28.0M | $-60.9M | $-57.0M | $-48.5M | $-46.7M |
| Diluted EPS | $-59.03 | $-129.63 | $-121.92 | $-102.24 | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SCHEDULE 13G/A2026-02-11
View on EDGAR →D2025-05-12
View on EDGAR →10-K2025-03-26
View on EDGAR →8-K2025-03-04
View on EDGAR →EFFECT2025-02-27
View on EDGAR →EFFECT2025-02-27
View on EDGAR →15-12G2025-02-27
View on EDGAR →S-8 POS2025-02-26
View on EDGAR →Largest Healthcare peers
Go deeper on SONX
Search Sonendo, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.